Ocera Therapeutics Names Jeryl Hilleman CFO

(RTTNews) - Ocera Therapeutics (OCRX) announced Tuesday that it appointed Jeryl Hilleman as its chief financial officer effective today. Hilleman will replace Dana McGowan who will continue with the company during a transition period in which the company plans to move its headquarters to Northern California.

Hilleman has over two decades experience as CFO of both private and public companies, including taking four companies public. Most recently, Hilleman has provided independent financial and strategic consulting for biotech and cleantech companies. From 2008 to 2012, Hilleman served as CFO of Amyris, Inc., a multi-national, renewable products company based in California and Brazil. Prior to Amyris, Hilleman served as CFO of Symyx Technologies, a public company selling instruments, software and research services to pharmaceutical and chemical companies, and led the finance function at two public biotechnology companies, Geron Corporation and Cytel Corporation.

Hilleman is also a member of the board of directors and chair of the audit committee of Xenoport (XNPT).